• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Successful Strategies for Pharmaceutical Reformulation Product Image

Successful Strategies for Pharmaceutical Reformulation

  • ID: 2013898
  • October 2011
  • 92 pages
  • Scripp Business Insights

This report assesses the various approaches to reformulation in the protection of revenues for pharmaceuticals that are in the midpoint of their lifecycles. Using case studies pulmonary, injectable, oral, and transdermal reformulation strategies are examined with key technologies profiled.

Features and benefits:

- Understand the commercial benefits of drug reformulation
- Understand the main drivers of uptake for specific drug delivery routes including, oral, transdermal, pulmonary, and injectable.
- Using case studies understand how to take a strategic approach to drug delivery based product development.
- Discover how you reformulation can grant extended patent protection and greatly extend the profitable lifecycle of your products.
- Analyse key technological developments in oral, injectable, pulmonary, and transdermal drug delivery and assess which will be most suitable for you.


- Novel formulations deliver superior returns on investments: drug delivery-based product development strategies are substantially more effective compared with Rx-to-OTC switching, or if companies followed new indication, branded generic, or drug repositioning READ MORE >

Note: Product cover images may vary from those shown

Reformulation, a strategy for success
Oral reformulation
Pulmonary reformulation
Injectable reformulation
Transdermal reformulation

Reformulation, a strategy for market success
Key industry factors associated with drug delivery-based product development
Market conditions
Demand for drug delivery-based products
Research and development issues
Initiating drug delivery-based product development: a strategic approach
A reformulation time plan to protect patents and sustain market share
Technological competencies
Strategic partnerships
A decade of reformulation success utilizing delivery technologies
Delivery technology focus: creating market leaders
Novartis’ Neoral (Sandimmune/cyclosporin).
Johnson & Johnson’s Duragesic (fentanyl).
Market size and trends for drug delivery-based products
Market share for the drug delivery-based reformulation sector
Oral reformulation

Oral reformulation
Biological barriers to oral delivery formulations
Oral reformulation systems
Types of technologies used in oral drug delivery
Market insights
Recent successful technological developments and opportunities for oral reformulations
Pulmonary reformulation

Pulmonary reformulation
Types of pulmonary formulations
Aqueous formulations
Formulations and devices
Types of device
Classes of inhaled drugs for respiratory diseases
Market insights and case studies for successful pulmonary reformulation
Inhalable insulin - a cautionary reformulation tale
Pfizer’s Exubera
Injectable reformulation

Injectable reformulation
Injectable drug delivery systems
Therapeutic focus for injectable reformulation
Current injectable anti-cancer drugs
Monoclonal antibodies
Central Nervous System: Injectable Reformulation Opportunities
Schizophrenia and substance abuse
Schizophrenia: current treatments
Substance abuse: current treatments
Market insights and opportunities for injectable reformulation
Transdermal reformulation

Transdermal reformulation
Skin structure and permeability
Benefits and limitations of transdermal drug delivery
Technologies to improve transdermal drug delivery
Liposomal reformulation

Therapeutic areas for transdermal reformulation
Leading transdermal products and market insights for successful reformulation
Transdermal reformulation: therapeutic and development focus
Alzheimer’s disease: Exelon Patch (rivastigmine), Novartis
Pain relief
Fentanyl patches
Women’s health
Estradot/Vivelle dot
Cardiovascular disease - hypertension and angina
Transdermal nitroglycerin
Generic opportunities for transdermal reformulations



Table: Commercial benefits of drug delivery technologies
Table: Types of strategic drug partnership
Table: Revenue-sustaining oral drug delivery-based products, 2000-($m)2010
Table: Revenue-sustaining pulmonary drug delivery-based products, 2000-2010, $m
Table: Revenue-sustaining injectable drug delivery-based products, ($m), 2000-2010
Table: Revenue-sustaining injectable drug delivery-based products, ($m), 2000-2010
Table: Revenue-sustaining pulmonary drug delivery-based products, ($m), 2000-2010
Table: Revenue-sustaining transdermal drug delivery-based products, ($m), 2000-2010
Table: Market size ($m) for drug delivery-based products by route of administration 2005 - 2009
Table: Advantages and disadvantages of orally delivered formulations
Table: Oral modified release systems
Table: Types of controlled release drug delivery systems
Table: Advantages and disadvantages for pulmonary reformulation
Table: Selected examples of proprietary dry powder inhalers
Table: Significant inhaled branded steroid products
Table: Successful pulmonary reformulation case study - Pulmicort
Table: Successful pulmonary reformulation case study - Advair/Seretide
Table: Advantages and disadvantages of injectable formulations
Table: Drivers and resistors of the use of injectable drug delivery reformulation
Table: Types of injectable drug delivery system
Table: Injectable reformulation focus: Acromegaly
Table: Injectable reformulation focus: Diabetes
Table: Injectable reformulation focus: Viral Infections
Table: Types of injectable pain-relief and routes of administration
Table: Patent expiries of leading sustained-release compounds
Table: Selected therapy areas utilizing sustained-release technologies
Table: Comparison of fentanyl patch formulations
Table: Estradot size types and dosages


Figure: Market forces affecting drug delivery-based products
Figure: Strategy to optimize R&D for the designated compound and related multiple drug delivery-based products
Figure: Revenue and patent protection achieved through reformulation
Figure: Patent extension and protection possibilities through multiple reformulation products
Figure: Market share of major reformulation sectors, 2005 and 2010
Figure: R&D drivers for new oral delivery technologies
Figure: Distribution of Global Cancer Burden by WHO Region (2008)
Figure: Breakdown of the transdermal reformulation market by therapy area

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Our clients' logos